newsfilter
← Latest News
Business Wire·

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

EQ

Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced